Order Article Reprints

Mir SA, Ara R, Amin F, Malik A, Hamid L, Ali T, Bader GN, Wani SUD, Almuqbil M, Alshehri S, et al. Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial. Medicina. 2022; 58(11):1503. https://doi.org/10.3390/medicina58111503

Mir, Suhail Ahmad, Rifat Ara, Fiza Amin, Anjum Malik, Laraibah Hamid, Tabasum Ali, Ghulam Nabi Bader, Shahid Ud Din Wani, Mansour Almuqbil, Sultan Alshehri, and et al. 2022. "Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial" Medicina 58, no. 11: 1503. https://doi.org/10.3390/medicina58111503

Mir, S. A., Ara, R., Amin, F., Malik, A., Hamid, L., Ali, T., Bader, G. N., Wani, S. U. D., Almuqbil, M., Alshehri, S., Alshehri, A. M., & Shakeel, F. (2022). Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial. Medicina, 58(11), 1503. https://doi.org/10.3390/medicina58111503